查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年鼻擴張器的全球市場
市場調查報告書
商品編碼
1217595

2022-2029 年鼻擴張器的全球市場

Global Internal Nasal Dilators Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

鼻孔擴張器是一種插入鼻孔的裝置，可幫助擴張鼻道並改善呼吸。 如果您因鼻息肉、鼻中隔偏曲或過敏等情況而出現鼻塞，它可能有助於緩解鼻塞並改善氣流。 有幾種類型的鼻孔擴張器，包括彈簧裝置、膠條和矽膠塞。 與其他治療選擇（例如噴鼻劑和口服藥物）一起，這些設備可以幫助控制鼻塞症狀。

市場動態

全球鼻擴張器市場的增長受到以下因素的推動：技術進步、鼻部疾病患病率上升、對鼻部疾病的認識提高、鼻部手術增多、生活方式改變和空氣污染加劇、醫療成本上升和轉向家庭護理。

打鼾和阻塞性睡眠呼吸暫停 (OSA) 疾病的患病率上升推動了市場增長

打鼾和阻塞性睡眠呼吸暫停 (OSA) 會導致白天過度嗜睡、機動車事故風險增加以及多種心血管和神經血管並發症。. 根據美國胸科學會 2020 年發表的一篇論文，阻塞性睡眠呼吸暫停 (OSA) 影響了全球 9.36 億 30 至 69 歲的成年人，其中約 4.25 億人患有中度疾病。估計患有中度至重度疾病。 在美國，據保守估計，6% 的女性和 13% 的男性患有具有臨床意義的 OSA，定義為 15 次或更多事件的呼吸暫停低通氣指數 (AHI)。 OSA 會留下嚴重的神經認知和心血管後遺症，並且難以進行最佳治療。

鼻擴張器也被建議用於阻塞性睡眠呼吸暫停綜合徵 (OSAS) 患者。 OSAS 是一種常見的睡眠障礙，具有嚴重的公共衛生後果。 幾項隨機對照試驗證明，持續氣道正壓通氣 (CPAP) 被認為是中度至重度 OSAS 患者的主要藥物治療。

鼻擴張器價格高阻礙市場增長

但是，某些鼻擴張器的高價格可能成為一些人的障礙並限制了他們的採用。 鼻擴張器的價格會因設備的類型和品牌而有很大差異。 有些很便宜，有些很貴。 例如，一包自粘式鼻孔擴張器的價格可能不到 10 美元，而僅需處方的彈簧式鼻孔擴張器可能要花費數百美元。 這些高昂的成本可能使一些人難以購買，尤其是購買沒有保險或免賠額高的設備。 此外，除了高成本之外，重要的是要指出保險公司缺乏報銷是影響鼻擴張器市場的一個因素。 這對製造商和消費者都是一個挑戰。 這對生產商和消費者來說都很難。 這可能會限制其使用，因為個人可能會選擇保險涵蓋的更便宜的治療方案。

COVID-19 影響分析

COVID-19 疫情對鼻擴張器市場產生了重大影響。 這些設備用於治療鼻塞和其他呼吸系統問題，但由於大流行，需求有所增加。 COVID-19 可引起鼻塞等呼吸道症狀，這可能導致對緩解這些症狀的產品的需求增加。 此外，許多人由於大流行的影響而感到焦慮和壓力，這可能會導致鼻塞。 此外，隨著遠程工作和遠程醫療在許多國家變得越來越普遍，越來越多的人正在尋求家庭護理來治療鼻塞等呼吸系統疾病。 對此類家庭治療的需求不斷增長，也推動了對口腔鼻擴張器的需求。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 對可定制和可重複使用的鼻內擴張器的需求不斷增加
      • 打鼾和阻塞性睡眠呼吸暫停 (OSA) 疾病的患病率增加
    • 約束因素
      • 設備成本高
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 羅紋類型
  • 平滑型

第 8 章使用

  • 重用
  • 一次性使用

第9章材料

  • 聚合物
  • 聚合物+合金
  • 其他

第 10 章應用

  • 打鼾
  • 鼻中隔偏斜
  • 鼻竇炎
  • 睡眠呼吸暫停綜合症
  • 其他

第 11 章按銷售渠道

  • 醫院藥房
  • 零售藥房
  • 在線藥店

第12章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第13章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 按類型劃分的基準

第14章公司簡介

  • Rhinomed 有限公司
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Splintek Inc
  • Nasanita
  • SHREYAAS HEALTH CARE PVT LTD
  • Scandinavian Formulas
  • Tomed GmbH
  • Nasilator
  • HealthRight Products, LLC
  • SIBEL, S.A.U.
  • GlaxoSmithKline

第15章 DataM

簡介目錄
Product Code: DMMD1439

Market Overview

The global internal nasal dilators market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Internal nasal dilators are devices inserted into the nostrils to help expand the nasal passages and improve breathing. They can help alleviate nasal congestion and improve airflow in people with nasal obstruction caused by conditions such as nasal polyps, deviated septum, or allergies. Several types of internal nasal dilators are available, including spring-loaded devices, adhesive strips, and silicone plugs. These devices can be used with other treatment options, such as nasal sprays or oral medications, to help manage symptoms of nasal obstruction.

Market Dynamics

The global internal nasal dilators market growth is driven by technological advancements, the rising prevalence of nasal disorders, increasing awareness of nasal disorders, the growing number of nasal surgery, changing lifestyles and increasing air pollution, increased healthcare expenditure, and a shift in focus towards home-based treatments.

An increasing prevalence of Snoring and obstructive sleep apnea (OSA) diseases drives the market growth

Snoring and obstructive sleep apnea (OSA) can induce excessive daytime sleepiness, increased risk of car accidents, and several cardiovascular and neurovascular medical complications. As per the article published in the American Thoracic Society in 2020, Obstructive sleep apnea (OSA) affects an estimated 936 million adults 30-69 years old worldwide, with approximately 425 million adults experiencing moderate to severe disease. In the U.S., conservative estimates suggest that 6% of women and 13% of men have clinically significant OSA, defined as an apnea-hypopnea index (AHI) of 15 events or greater. OSA has major neurocognitive and cardiovascular sequelae, but optimal treatment can be challenging.

Nasal dilators have also been proposed in patients with obstructive sleep apnea syndrome (OSAS). OSAS is a prevalent sleep disorder with significant public health outcomes. Continuous positive airway pressure (CPAP) is considered the primary medical treatment for patients with moderate to severe OSAS, as evidenced by several randomized controlled trials.

High cost of internal nasal dilators will hamper the growth of the market

However, the high cost of some internal nasal dilators can be a barrier for some individuals and may limit their adoption. Prices for internal nasal dilators can vary widely, depending on the type of device and the brand. Some internal nasal dilators can be inexpensive, while others can be quite costly. For example, a pack of adhesive nasal strips may cost less than $10, while a prescription-only, spring-loaded nasal dilator can cost several hundred dollars. These high costs may make it difficult for some individuals to afford the devices, especially those without insurance coverage or with high deductibles. Additionally, to the high cost, it is important to mention the lack of reimbursement by the insurance company as a factor that will impact on internal nasal dilator market; this can be challenging for both manufacturers and consumers. This can limit their use, as individuals may opt for cheaper treatment options covered by their insurance.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the market for internal nasal dilators. These devices are used to treat nasal congestion and other breathing-related issues, and demand for them has increased due to the pandemic. One reason is that COVID-19 can cause respiratory symptoms such as nasal congestion, which has increased demand for products that can help alleviate these symptoms. Additionally, many people have been experiencing anxiety and stress related to the pandemic, which can cause nasal congestion. Moreover, many countries have seen an increase in remote working and telemedicine, leading to more people seeking treatment for nasal congestion and other breathing issues from their homes. This increased demand for at-home treatments has also helped boost demand for internal nasal dilators.

Segment Analysis

The sleep apnea segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The sleep apnea segment accounts for the highest market share. The nasal valve area has a minimal cross-sectional area of the upper airways. Obstructive sleep apnea syndrome (OSAS) is a common disorder. It has been reported that nasal obstruction may be associated with OSAS.

McKeon Products offers AIRMAX Nasal Dilator for Better Sleep - Two Size Trial Pack - (Small and Medium - Clear), a simple solution for individuals who have sleeping and breathing difficulties; designed to be comfortably placed inside the nasal passages - it is patented, aerodynamic winged design is clinically proven to help improve airflow by expanding the nasal passages, Clinically proven to help reduce snoring and mild sleep apnea. To relieve nasal congestion, An FDA cleared medical device made of hypoallergenic, medical grade material that is soft, flexible and comfortable; more effective than Breathe Right Nasal Strips, Available in medium (fits most) and small, and includes a carrying case and A patented design.

Geographical Analysis

North America region holds the largest market share of the global Internal Nasal Dilators market

North America dominates the market for internal nasal dilators and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of nasal disorders, and product launches by market players in the North American region drive the market.

Sinusitis is one of the most common chronic conditions in the United States, affecting fifty million Americans, 20% of the nation's population. Sinusitis is a chronic (ongoing) disease that includes the symptoms of nasal obstruction (difficulty breathing through the nose), nasal drainage, decreased sense of smell, facial pressure, and frequent sinus infections.

As per the UCI Health, Nose and sinus disorders afflict millions of people, causing pain, fatigue, headache, breathing difficulties and loss of smell, among other symptoms. Sinusitis alone affects about 37 million people at least once yearly, making it one of the most common illnesses in the United States.

Competitive Landscape

The internal nasal dilators market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Rhinomed Limited, Splintek Inc, Nasanita, SHREYAAS HEALTH CARE PVT LTD, Scandinavian Formulas, Airware Labs, Tomed GmbH, Nasilator, HealthRight Products, LLC, SIBEL, S.A.U., and GlaxoSmithKline plc, among others. The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the internal nasal dilators market globally.

Rhinomed Limited

Overview:

Rhinomed is an airway technology organization that seeks to improve how you breathe radically, sleep, maintain your health and take medication. Rhinomed's patented nasal technology leverages the physiology of the nose to optimize our breathing which is essential to restful sleep and maintaining good health.

Product Portfolio:

MUTE TRIAL PACK: A nasal breathing device called Mute softly opens your airways to boost airflow via your nose as you sleep.

The global internal nasal dilators market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Customized and Reusable Internal Nasal Dilators
      • 4.1.1.2. An increasing prevalence of Snoring and obstructive sleep apnea (OSA) diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Ribbed Type*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Smooth

8. By Usability

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 8.1.2. Market Attractiveness Index, By Usability
  • 8.2. Reusable*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Single Use

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Polymer*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Polymer + Alloy
  • 9.4. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Snoring*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Deviated Septum
  • 10.4. Sinusitis
  • 10.5. Sleep Apnea
  • 10.6. Others

11. By Distribution Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2. Market Attractiveness Index, By Distribution Channel
  • 11.2. Hospitals Pharmacies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Retail Pharmacies
  • 11.4. Online Pharmacies

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Type Benchmarking

14. Company Profiles

  • 14.1. Rhinomed Limited*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Splintek Inc
  • 14.3. Nasanita
  • 14.4. SHREYAAS HEALTH CARE PVT LTD
  • 14.5. Scandinavian Formulas
  • 14.6. Tomed GmbH
  • 14.7. Nasilator
  • 14.8. HealthRight Products, LLC
  • 14.9. SIBEL, S.A.U.
  • 14.10. GlaxoSmithKline

LIST NOT EXHAUSTIVE

15. Global Internal Nasal Dilators Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us